Tornier BV, a Dutch medical device company focused on surgeons that treat musculoskeletal injuries and disorders, has filed for a $205 million IPO. It plans to trade on the Nasdaq under ticker symbol TRNX, with BoA Merrill Lynch and J.P. Morgan serving as co-lead underwriters.
The company reports around $201 million in 2009 revenue, which is up from $177 million in 2008. Consolidated net loss grew to $55 million from $34 million.
Shareholders include Warburg Pincus, The Vertical Group and company management.